Bayer CropScience Limited reports Q1 Results for FY 2026-27

  • Business & Finance
  • Revenue from Operations of ₹18,350 million
  • Profit Before Tax of ₹4,021 million
Green banner displaying 'Bayer CropScience Ltd' and 'Q1 Results FY 2026-27' in white text with a gradient background.

Mumbai, August 05, 2026: Bayer CropScience Limited (BSE: 506285) announced today its unaudited results for the first quarter (Q1) of Financial Year (FY) 2026-27. For Q1 ended June 30, 2026, the Company reported Revenue from Operations of ₹18,350 million, lower by 4% year-on-year. Profit Before Tax increased by 20% year-on-year to ₹4,021 million.

Simon Wiebusch, Vice Chairman & Managing Director and CEO, Bayer CropScience Limited, commented on the quarterly results, “We delivered a resilient start to FY2026-27, with our performance reflecting disciplined execution amid challenging weather and evolving market conditions. The quarter reflected market dynamics across regions and product offerings. Corn seeds sustained momentum despite an overall decline in acreage, supported by the strength of our hybrids and focused customer engagement. As weather variability, including the potential impact of El Niño conditions, and evolving geopolitical developments continue to shape the operating environment, the company remains focused on proactive channel management, advancing our portfolio-led innovation, and creating sustainable value for farmers and stakeholders.

Vinit Jindal, Executive Director and Chief Financial Officer, Bayer CropScience Limited, added, “Profit After Tax increased by 15% during the quarter, supported by improved gross margins driven by favorable pricing actions and a stronger product mix. The quarter also benefitted from an income of ₹ 639 million arising from the divestment of marketing rights for formulated products. Other operating expenses were higher compared with the corresponding quarter of the previous year. Improving working capital performance through inventory optimization and collections remains a key area of focus."

 

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2025, the Group employed around 88,000 people and had sales of 45.6 billion euros. R&D expenses amounted to 5.8 billion euros. For more information, go to www.bayer.com.

 

Media Contact

Snigdha Vishal
Communications, Bayer CropScience Limited
Email: snigdha.vishal@bayer.com

 

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.